JR Handy, RM Bremner… - The Annals of …, 2019 - annalsthoracicsurgery.org
17. When managing NSGCTs, PM is indicated for select patients with limited number of lung abnormalities after first-line or second-line platin-based chemotherapy suspected of …
Importance Even though 15% to 50% of patients with head and neck squamous cell carcinoma (HNSCC) experience recurrence, relatively little is known regarding patterns of …
Management of metastatic head and neck squamous cell carcinoma is evolving as new systemic therapies have led to improvements in survival, and as advances in locoregional …
Simple Summary The purpose of this manuscript is to illustrate the difficulties associated with the treatment of the patient with recurrent metastatic SCCHN. This type of patient is very …
AS Ho, GJ Tsao, FW Chen, T Shen, MJ Kaplan… - Cancer, 2013 - Wiley Online Library
BACKGROUND: In head and neck cancer (HNC), 3‐month post‐treatment positron emission tomography (PET)/computed tomography (CT) reliably identifies persistent/recurrent …
FPY Cheung, NZ Alam, GM Wright - Annals of Thoracic and …, 2019 - jstage.jst.go.jp
Pulmonary metastases are a sign of advanced malignancy and an omen of poor prognosis. Once primary tumors metastasize, they become notoriously difficult to treat and …
F Petrella, C Diotti, A Rimessi… - Journal of thoracic …, 2017 - ncbi.nlm.nih.gov
Metastasectomy is the most frequent surgical resection undertaken by thoracic surgeons, being the lung the second common site of metastases. The present oncological criteria for …
Despite recent advances in oncologic therapy, an important proportion of patients with primary cancer will develop distant metastasis. The standard therapy for metastatic cancer is …
ER Young, E Diakos, M Khalid‐Raja… - Clinical …, 2015 - Wiley Online Library
Background Pulmonary metastasectomy involves the surgical removal of pulmonary nodules. It is a recognised therapeutic modality for the treatment of metastatic disease …